Health systems in transition : Uzbekistan

Social Science & 
Medicine
, 51(11):1611–1625.
Chemrar (2013). 
Перспективы
 
развития
 
фармацевтического
 
рынка
 
Узбекистана
 
[The prospects for the development of the pharmaceutical market in Uzbekistan]
. 
Moscow, Chemrar (
http://www.chemrar.ru/i-news/index.php?ELEMENT_ID=15492
, 
accessed 1 October 2013).
Chren M, Landefeld C, Murray TH (1989). Doctors, drug companies, and gifts. 
Journal of 
the American Medical Association
, 262(24):3448–3451.
Donabedian A (1988). The quality of care: how can it be assessed? 
Journal of the American 
Medical Association
, 260(12):1743–1748.
Duran A et al. (2012). Understanding health systems: scope, functions and objectives. 
In: Figueras J, McKee M, eds. 
Health systems, health, wealth and societal well-being
. 
Maidenhead, Open University Press:19–36.
Emanuel B (2010). 
Consultant report. On improving laboratory diagnostics and optimizing 
laboratory networks in Ferghana oblast
. Tashkent.
Expert-Fikri (2011). 
Health II – Final evaluation report
. Tashkent, Expert-Fikri.
Footman K et al. (2013). Public satisfaction as a measure of health system performance: 
a study of nine countries in the former Soviet Union. 
Health Policy
, 112(1):62–69.
Fuenzalida-Puelma HL et al. (2010). Purchasing of health care services. In: Kutzin J, Cashin 
C, Jakab B, eds. 
Implementing Health Financing Reform: Lessons from Countries in 
Transition
. Copenhagen, World Health Organization:155–186.
GMC (2014). Professional and Linguistic Assessments Board (PLAB). London, General 
Medical Council (
http://www.gmc-uk.org/doctors/plab.asp
, accessed 12 June 2014). 
Gulliford M et al. (2002). What does ‘access to health care’ mean? 
Journal of Health Services 
Research & Policy
, 7(3):186–188.
Hasker E et al. (2009). Drug prescribing practices for tuberculosis in Uzbekistan. 
International Journal of Tuberculosis and Lung Disease
, 13(11):1405–1410.
Hasker E et al. (2010). Why do tuberculosis patients default in Tashkent City, Uzbekistan? A 
qualitative study. 
International Journal of Tuberculosis and Lung Disease
, 14(9):1132–1139.
Hockenberry JM et al. (2011). Financial payments by orthopedic device makers to orthopedic 
surgeons. 
Archives of Internal Medicine
, 171(19):1759–1765.
IHME (2014). Global burden of disease country profiles. Seattle, Institute for Health Metrics 
and Evaluation (
http://www.healthdata.org/results/country-profiles
, accessed 12 June 2014).
Ilkhamov FA, Jakubowski E, Hajioff S (2001). Uzbekistan: health system review. 
Health 
Systems in Transition
, 3(6):1–74. 
Jha AK et al. (2009). Measuring efficiency: the association of hospital costs and quality of 
care. 
Health Affairs
, 28(3):897–906.
Kuchkarov D, Haydarov A (2004). Local budgets through the prism of problems [in Russian]. 
Ekonomicheskoe obozrenie [Economic review]
, 6.

---

Health systems in transition
  
Uzbekistan
130
Mamatkulov B (2013). 
Public health and health management
. Tashkent, Ilm Ziyo.
MCC (2014). Examinations. Ottawa, Medical Council of Canada (
http://mcc.ca/examinations/
, 
accessed 12 June 2014).
Measure DHS (2002). 
Health examination survey
. Calverton, MD, Measure DHS.
Mello MM et al. (2007). Who pays for medical errors? An analysis of adverse event costs, 
the medical liability system, and incentives for patient safety improvement.